We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Cerner Corp (CERN) Common Stock USD0.01

Sell:$93.77 Buy:$93.78 Change: $0.14 (0.15%)
NASDAQ:2.69%
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Cerner Corp Common Stock USD0.01

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 17 May 2022)

The cash offer made by Oracle Corporation for Cerner Corp Inc has been extended. The purchaser is offering to buy shares at USD95.00 per share.

 

If you don’t want to accept the offer you don’t need to do anything at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining shares at a later date. 

 

You can accept the offer by giving an instruction below before noon on Tuesday 31 May 2022.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$93.77
Buy:$93.78
Change: $0.14 (0.15%)
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Cerner Corp Common Stock USD0.01

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 17 May 2022)

The cash offer made by Oracle Corporation for Cerner Corp Inc has been extended. The purchaser is offering to buy shares at USD95.00 per share.

 

If you don’t want to accept the offer you don’t need to do anything at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining shares at a later date. 

 

You can accept the offer by giving an instruction below before noon on Tuesday 31 May 2022.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$93.77
Buy:$93.78
Change: $0.14 (0.15%)
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Cerner Corp Common Stock USD0.01

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 17 May 2022)

The cash offer made by Oracle Corporation for Cerner Corp Inc has been extended. The purchaser is offering to buy shares at USD95.00 per share.

 

If you don’t want to accept the offer you don’t need to do anything at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining shares at a later date. 

 

You can accept the offer by giving an instruction below before noon on Tuesday 31 May 2022.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cerner Corporation (Cerner) is a supplier of healthcare information technology. The Company offers intelligent solutions and technology-enabled services that support the clinical, financial and operational needs of organizations. The Company's segments include Domestic segment includes revenue contributions and expenditures associated with business activity in the United States, and the International segment includes revenue contributions and expenditures linked to business activity outside the United States, primarily from Australia, Canada, Europe, and the Middle East. It also offers integrated clinical and financial systems to help manage day-to-day revenue functions to support clinical, financial and operational needs. Cerner's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform. Cerner also has an electronic health record (EHR) agnostic platform, CareAware, which facilitates connectivity of healthcare devices to EHRs.

Contact details

Address:
2800 ROCKCREEK PKWY
W0162, ATTN: CERNER LEGAL
NORTH KANSAS CITY
64117
United States
Telephone:
+1 (816) 2211024
Website:
https://www.cerner.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CERN
ISIN:
US1567821046
Market cap:
$27.64 billion
Shares in issue:
294.10 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • David Feinberg
    President, Chief Executive Officer, Director
  • Mark Erceg
    Chief Financial Officer, Executive Vice President
  • Tracy Platt
    Executive Vice President, Chief Human Resources Officer
  • Jerome Labat
    Executive Vice President, Chief Technology Officer
  • Nasim Afsarmanesh
    Executive Vice President, Chief Health Officer
  • Travis Dalton
    Executive Vice President, Chief Client & Services Officer and President, Cerner Government Services
  • Daniel Devers
    Executive Vice President and Chief Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.